Loading clinical trials...
Loading clinical trials...
Randomized Controlled Clinical Trials of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)
Conditions
Interventions
Lopinavir/ritonavir
Hydroxychloroquine sulfate
Locations
1
South Korea
Asan Medical Center, University of Ulsan College of Medicine
Seoul, South Korea
Start Date
March 11, 2020
Primary Completion Date
April 30, 2020
Completion Date
April 30, 2020
Last Updated
May 27, 2020
NCT07221162
NCT06082518
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
Asan Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions